{"log_id": 793320403229730921, "direction": 0, "words_result_num": 56, "words_result": [{"probability": {"variance": 3e-06, "average": 0.998154, "min": 0.99269}, "location": {"width": 225, "top": 144, "height": 23, "left": 213}, "words": "核准日期:2007年04月03日"}, {"probability": {"variance": 4.7e-05, "average": 0.996415, "min": 0.963185}, "location": {"width": 668, "top": 162, "height": 33, "left": 212}, "words": "修改日期:2010年09月25日2013年06月18日2014年06月05日2014年10月20日"}, {"probability": {"variance": 8e-06, "average": 0.99831, "min": 0.986419}, "location": {"width": 279, "top": 193, "height": 22, "left": 309}, "words": "2015年12月01日2016年10月27日"}, {"probability": {"variance": 2.3e-05, "average": 0.997769, "min": 0.982391}, "location": {"width": 370, "top": 231, "height": 40, "left": 390}, "words": "注射用盐酸阿糖胞苷说明书"}, {"probability": {"variance": 0.000114, "average": 0.991006, "min": 0.969133}, "location": {"width": 75, "top": 313, "height": 21, "left": 223}, "words": "【药品名称】"}, {"probability": {"variance": 0.003275, "average": 0.977728, "min": 0.780698}, "location": {"width": 204, "top": 331, "height": 25, "left": 240}, "words": "通用名称注射用盐酸阿糖胞苷"}, {"probability": {"variance": 0.0202, "average": 0.91949, "min": 0.584921}, "location": {"width": 82, "top": 357, "height": 16, "left": 242}, "words": "英文名称:Cy"}, {"probability": {"variance": 0.004944, "average": 0.937953, "min": 0.836872}, "location": {"width": 82, "top": 376, "height": 18, "left": 242}, "words": "汉语拼音Zh"}, {"probability": {"variance": 9.7e-05, "average": 0.989719, "min": 0.979857}, "location": {"width": 76, "top": 396, "height": 19, "left": 220}, "words": "成份"}, {"probability": {"variance": 0.021486, "average": 0.922812, "min": 0.401613}, "location": {"width": 698, "top": 411, "height": 23, "left": 242}, "words": "化学名称:本品主要成份为盐酸阿糖胞苷,其化学名为1-β-D-阿拉伯呋喃糖基4氨基2(H)-嘧啶酮盐酸盐"}, {"probability": {"variance": 7.2e-05, "average": 0.993624, "min": 0.981097}, "location": {"width": 79, "top": 438, "height": 18, "left": 244}, "words": "化学结构式:"}, {"probability": {"variance": 0, "average": 0.760724, "min": 0.760724}, "location": {"width": 31, "top": 470, "height": 31, "left": 560}, "words": " NE"}, {"probability": {"variance": 0, "average": 0.979275, "min": 0.979275}, "location": {"width": 20, "top": 569, "height": 20, "left": 673}, "words": " HC"}, {"probability": {"variance": 0.044596, "average": 0.806966, "min": 0.392507}, "location": {"width": 154, "top": 680, "height": 21, "left": 245}, "words": "分子式:CH13N3O·HO"}, {"probability": {"variance": 0.01745, "average": 0.918082, "min": 0.553872}, "location": {"width": 94, "top": 703, "height": 16, "left": 245}, "words": "分子量:279.68"}, {"probability": {"variance": 1.3e-05, "average": 0.997316, "min": 0.992294}, "location": {"width": 66, "top": 722, "height": 20, "left": 246}, "words": "辅料无"}, {"probability": {"variance": 0.000145, "average": 0.987176, "min": 0.970283}, "location": {"width": 75, "top": 743, "height": 19, "left": 225}, "words": "【性状"}, {"probability": {"variance": 0.000326, "average": 0.993005, "min": 0.930817}, "location": {"width": 201, "top": 761, "height": 23, "left": 244}, "words": "本品为白色疏松块状物或粉末"}, {"probability": {"variance": 1.6e-05, "average": 0.996079, "min": 0.990511}, "location": {"width": 69, "top": 786, "height": 17, "left": 229}, "words": "适应症"}, {"probability": {"variance": 0.007227, "average": 0.970863, "min": 0.503114}, "location": {"width": 704, "top": 798, "height": 27, "left": 242}, "words": "适用于急性白血病的诱导授解期及维持巩固期。对急性非淋巴细胞性白血病效果较好,对慢性粒细胞白血"}, {"probability": {"variance": 5.6e-05, "average": 0.995734, "min": 0.971349}, "location": {"width": 215, "top": 825, "height": 19, "left": 216}, "words": "病的急变期,恶性淋巴也有效"}, {"probability": {"variance": 0.029277, "average": 0.841188, "min": 0.602136}, "location": {"width": 70, "top": 847, "height": 19, "left": 228}, "words": "[规格"}, {"probability": {"variance": 0, "average": 0.849116, "min": 0.849116}, "location": {"width": 33, "top": 867, "height": 16, "left": 250}, "words": " omg"}, {"probability": {"variance": 0.000182, "average": 0.987411, "min": 0.968422}, "location": {"width": 65, "top": 886, "height": 20, "left": 233}, "words": "用法用"}, {"probability": {"variance": 4e-06, "average": 0.997275, "min": 0.993923}, "location": {"width": 76, "top": 907, "height": 18, "left": 267}, "words": "成人常用量"}, {"probability": {"variance": 0.001287, "average": 0.98174, "min": 0.849642}, "location": {"width": 359, "top": 924, "height": 21, "left": 251}, "words": "(1)诱导缓解:静脉注射或滴注一次按体重 2mg/kg或"}, {"probability": {"variance": 0.004956, "average": 0.975204, "min": 0.69627}, "location": {"width": 222, "top": 922, "height": 20, "left": 727}, "words": "日1次,连用10~14日,如无明显"}, {"probability": {"variance": 0.002219, "average": 0.983737, "min": 0.809478}, "location": {"width": 232, "top": 946, "height": 20, "left": 217}, "words": "不良反应,剂量可增大至一次按体"}, {"probability": {"variance": 0.022388, "average": 0.923684, "min": 0.427142}, "location": {"width": 648, "top": 961, "height": 27, "left": 246}, "words": "2】维持:完全缓解后改用维持治疗量,一次按体重1mgkg,一日1-2次,皮下注射,连用710日"}, {"probability": {"variance": 0.007076, "average": 0.930039, "min": 0.756914}, "location": {"width": 102, "top": 987, "height": 19, "left": 271}, "words": "中剂量阿糖胞苷"}, {"probability": {"variance": 0.011546, "average": 0.957111, "min": 0.355221}, "location": {"width": 699, "top": 1000, "height": 29, "left": 239}, "words": "中剂量是指阿糖胞苷的剂量为一次按体表面积0.5-1.0g/m2的方案,一般需静滴1一3小时,一2次,以2"}, {"probability": {"variance": 0.006734, "average": 0.94526, "min": 0.742251}, "location": {"width": 356, "top": 1024, "height": 27, "left": 221}, "words": "5日为一疗程:大剂量阿糖胞苷的剂量为按体表面积为"}, {"probability": {"variance": 0.007868, "average": 0.973712, "min": 0.571565}, "location": {"width": 334, "top": 1023, "height": 20, "left": 608}, "words": "g/m的方案,静滴及疗程同中剂量方案,由于阿"}, {"probability": {"variance": 0.005269, "average": 0.972304, "min": 0.58256}, "location": {"width": 731, "top": 1042, "height": 28, "left": 217}, "words": "胞苷的不良反应随剂量增大而加重,有时反而限制了其疗效,故现多偏向用中剂量方案。中或大剂量阿糖胞"}, {"probability": {"variance": 0.011444, "average": 0.968268, "min": 0.469646}, "location": {"width": 730, "top": 1063, "height": 28, "left": 219}, "words": "苷主要用于治疗难治性或复发性急性白血病,亦可用于急性自血病的缓解后,延长其缓解期。由于不良反应"}, {"probability": {"variance": 0.005993, "average": 0.980015, "min": 0.520589}, "location": {"width": 598, "top": 1086, "height": 25, "left": 218}, "words": "较多,故疗程中必须由有丰富经验的医生指导,并要有充分及时的支持疗法保证方可进行"}, {"probability": {"variance": 0, "average": 0.914503, "min": 0.914503}, "location": {"width": 94, "top": 1025, "height": 97, "left": 942}, "words": "目"}, {"probability": {"variance": 0.003331, "average": 0.954636, "min": 0.830389}, "location": {"width": 104, "top": 1111, "height": 18, "left": 270}, "words": "小剂量阿糖胞苷"}, {"probability": {"variance": 0.00882, "average": 0.964392, "min": 0.68347}, "location": {"width": 157, "top": 1130, "height": 21, "left": 250}, "words": "剂量为一次按体表面积"}, {"probability": {"variance": 0.004212, "average": 0.972829, "min": 0.664795}, "location": {"width": 465, "top": 1124, "height": 23, "left": 477}, "words": "皮下注射,一日2次,以14一21日为一疗程,如不缓解而患者情况容许"}, {"probability": {"variance": 0.00779, "average": 0.974018, "min": 0.451433}, "location": {"width": 668, "top": 1147, "height": 24, "left": 280}, "words": "周重复一疗程。本方案主要用于治疗原始细胞增多或囊增生异常综合征患者,亦可治疗低增生性"}, {"probability": {"variance": 0.002221, "average": 0.983461, "min": 0.795004}, "location": {"width": 285, "top": 1170, "height": 24, "left": 222}, "words": "急性白血病、老年性急性淋巴细胞自血病等"}, {"probability": {"variance": 0.005127, "average": 0.95826, "min": 0.834242}, "location": {"width": 62, "top": 1193, "height": 18, "left": 271}, "words": "鞘内注射"}, {"probability": {"variance": 0.000996, "average": 0.987567, "min": 0.854827}, "location": {"width": 436, "top": 1208, "height": 28, "left": 241}, "words": "阿檐胞苷为鞘内注射防治脑膜白血病的第二线药物,剂量为"}, {"probability": {"variance": 0.00536, "average": 0.969152, "min": 0.741291}, "location": {"width": 160, "top": 1206, "height": 22, "left": 791}, "words": "联用地塞米松5mg.用"}, {"probability": {"variance": 0.004321, "average": 0.968412, "min": 0.761095}, "location": {"width": 163, "top": 1234, "height": 18, "left": 237}, "words": "10.9%氯化钠注射液溶解"}, {"probability": {"variance": 0.016714, "average": 0.945491, "min": 0.469166}, "location": {"width": 413, "top": 1228, "height": 25, "left": 460}, "words": "射,每周1一2次,至脑脊液正常,如为预防性则每4-8周一次"}, {"probability": {"variance": 0.000833, "average": 0.984767, "min": 0.927081}, "location": {"width": 69, "top": 1255, "height": 18, "left": 236}, "words": "【不良反应"}, {"probability": {"variance": 0, "average": 0.965863, "min": 0.965863}, "location": {"width": 18, "top": 1258, "height": 19, "left": 461}, "words": "G"}, {"probability": {"variance": 0.018192, "average": 0.940432, "min": 0.423303}, "location": {"width": 597, "top": 1267, "height": 30, "left": 270}, "words": "造血系统:主要骨髓摄制,白细胞及血小板减少,严者可发生再生障碍性贫血或巨幼"}, {"probability": {"variance": 0, "average": 0.999537, "min": 0.999106}, "location": {"width": 43, "top": 1269, "height": 19, "left": 899}, "words": "性贫血"}, {"probability": {"variance": 0.008715, "average": 0.969543, "min": 0.491447}, "location": {"width": 503, "top": 1290, "height": 26, "left": 271}, "words": "白血病,淋巴瘤患者治疗初期可发生高尿酸血症,严重者可发生尿酸性肾病"}, {"probability": {"variance": 0.013664, "average": 0.961503, "min": 0.36136}, "location": {"width": 683, "top": 1309, "height": 25, "left": 271}, "words": "较少见的有口腔炎食管炎肝功能异常发热反应及血栓性静脉炎,阿糖胞苷综合征多出现于用"}, {"probability": {"variance": 0, "average": 0.999599, "min": 0.999367}, "location": {"width": 33, "top": 1338, "height": 18, "left": 222}, "words": "药后"}, {"probability": {"variance": 0.009898, "average": 0.958761, "min": 0.515371}, "location": {"width": 463, "top": 1333, "height": 24, "left": 304}, "words": "时,有骨痛或肌痛、咽痛,发热全身不适、皮疹、眼睛发红等表现"}, {"probability": {"variance": 0, "average": 0.876858, "min": 0.876858}, "location": {"width": 72, "top": 1354, "height": 28, "left": 472}, "words": "2"}], "language": 3}